AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-248393659/oxygen-biotherapeutics-and-hackensack.html" title="Facts and information about Oxygen Biotherapeutics and Hackensack University Medical Center sign research contract funded by the US Department of Defense to study wound healing properties of Wundecyte gel.">Oxygen Biotherapeutics and Hackensack University Medical Center sign research contract funded by the US Department of Defense to study wound healing properties of Wundecyte gel.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Oxygen Biotherapeutics and Hackensack University Medical Center sign research contract funded by the US Department of Defense to study wound healing properties of Wundecyte gel.
Oxygen Biotherapeutics Inc announced it has signed a research contract with Hackensack University Medical Center (HUMC) to research wound healing properties of the Oxygen Biotherapeutics' Wundecyte perfluorocarbon (PFC) and its novel oxygen-producing bandage for treatment of full-thickness excisional wounds and partial thickness burns. The pre-clinical study will also evaluate Wundecyte's ability to prevent scar formation and …
Related articles from newspapers, magazines, journals, and more
